Exploring the Role of Artificial Intelligence in Revolutionizing Microbial Diagnostics

Abstract

Identifying the microorganisms responsible for illnesses and infections is crucial for accurate diagnosis, which is an essential aspect of providing medical care. Artificial intelligence (AI) systems can enhance drug discovery, epidemiological monitoring, prediction of antibiotic resistance, and disease management in the field of microbiological diagnosis. Artificial intelligence (AI) is a branch of science and technology that uses computers to simulate human intelligence. AI has recently shown tremendous promise as a powerful computational tool for the detection and management of bacterial infections. These machines can imitate human thought processes and cognitive capacities. Today, pathogen identification and Antimicrobial Susceptibility Testing (AST) in clinical laboratories often rely on culturing and isolating pathogens. With the rapid advancement of technology, Artificial Intelligence (AI) has become a vital tool for bacterial AST, providing numerous fast and efficient methods for testing drug susceptibility. AI systems offer enhanced diagnostic methods and early detection of antibiotic resistance. Moreover, they can rapidly and accurately identify diseases, including those that are novel or drug-resistant. In addition, AI can be applied to identify cells infected with malaria, detect drug resistance in pathogens like tuberculosis (TB) and HIV, understand and tackle antimicrobial resistance (AMR), and predict outbreaks. The primary goals of applying AI to bacterial diagnosis are the rapid and precise identification of pathogens and the prediction of drug resistance.